Scailyte Company
Scailyte is a company that specializes in biomarker discovery using a data-driven platform that combines single-cell data analysis and artificial intelligence. They focus on discovering disease-associated biomarkers using a phenotypic approach, which increases the success rate of discovering sensitive and robust biomarkers. Scailyte also develops analytical pipelines to translate data into clinical applications through single-cell science.
Investors
Connections
Founded Date:
2017
Last Funding Type:
Series A
Headquarters:
Basel, Basel-Stadt, Switzerland
Investors Number:
8
Technology:
Artificial Intelligence, Biotechnology, Health Diagnostics, Medical
Employee Number:
11-50
Industry:
Omics-Based Biomarkers
Estimated Revenue:
Less than $1M
Last Funding Date:
2022-09-21
Number Of Exists:
11-50
Funding Status:
Early Stage Venture
Total Funding:
13747507